Inappropriate chemotherapy decisions may occur through use of a commonly used formula that overestimates the risk of a cardiac adverse event, warn researchers. Many cancer drugs carry a risk of QT ...

Researchers have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. Researchers from Mayo Clinic and AliveCor Inc.

AliveCor is also offering a service called InstantQT™ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...